Related Funds
Fund Name | Location |
Beststudy | China, Guangdong, Guangzhou |
China Telcom | Beijing, Beijing, China |
GOODWILL Ventures | Levittown, New York, United States |
Infosys Foundation | California, Palo Alto, United States |
Innosight Ventures | Central Region, Singapore, Singapore |
Jumbofund | - |
Juvenescence | Isle of Man, Middle, NA - Isle of Man |
Origin Capital Management | California, San Francisco, United States |
Qi An Xin | Beijing, Beijing, China |
Telenor | Akershus, Fornebu, Norway |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Skip Therapeutics | 01 May 2021 | Ness Ziona, HaMerkaz, Israel | |||
A2i Therapeutics | 18 Dec 2020 | Ness Ziona, HaMerkaz, Israel | |||
Selene Therapeutics | 01 Oct 2020 | Ness Ziona, HaMerkaz, Israel | |||
Circuit-Bio | 01 Sep 2020 | - | |||
JAMM Therapeutics | 01 May 2020 | Ness Ziona, HaMerkaz, Israel | |||
Epeius Pharma Ltd. | 15 Jan 2020 | Ness Ziona, HaMerkaz, Israel | |||
GliXogen Therapeutics | 14 Jan 2019 | - | |||
MOYA Bio | 01 Jan 2019 | Ness Ziona, HaMerkaz, Israel | |||
Bsense Bio Therapeutics | $405K | 01 Oct 2018 | Ness Ziona, HaMerkaz, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Skip Therapeutics | 01 May 2021 | Ness Ziona, HaMerkaz, Israel | |||
A2i Therapeutics | 18 Dec 2020 | Ness Ziona, HaMerkaz, Israel | |||
Selene Therapeutics | 01 Oct 2020 | Ness Ziona, HaMerkaz, Israel | |||
Circuit-Bio | 01 Sep 2020 | - | |||
JAMM Therapeutics | 01 May 2020 | Ness Ziona, HaMerkaz, Israel | |||
Epeius Pharma Ltd. | 15 Jan 2020 | Ness Ziona, HaMerkaz, Israel | |||
GliXogen Therapeutics | 14 Jan 2019 | - | |||
MOYA Bio | 01 Jan 2019 | Ness Ziona, HaMerkaz, Israel | |||
Bsense Bio Therapeutics | $405K | 01 Oct 2018 | Ness Ziona, HaMerkaz, Israel |